King Khaled Eye Specialist Hospital
Riyadh, 11462, Saudi Arabia
NCT Number: NCT00238862
Patients with persistent corneal epithelial defects who have not responded to conventional therapy will be randomized to treatment with either amniotic membrane transplantation or autologous serum 20%. Outcome measures will be (1) presence or absence of complete re-epithelialization within 28 days and (2) retention of intact epithelium for at least 90 days.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Riyadh, 11462, Saudi Arabia
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
King Khaled Eye Specialist Hospital
Other Gov
Efficacy of Amniotic Membrane Transplantation and Autologous Serum in Treatment of Persistent Epithelial Defects
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07120308
Corneal Epithelial Defect
Xiamen, Fujian, China
View Trial DetailsNCT06213727
Corneal Epithelial Defect
Jinan, Shandong, China
View Trial DetailsNCT01075347
Cardiovascular Diseases, Corneal Epithelial Defect
Taipei, Taiwan
View Trial DetailsNCT06406439
Diabetes (Insulin-requiring, Type 1 or Type 2), Diabetes Mellitus
Gwangmyeong, Deokan-ro, South Korea
View Trial Details